Start here if you're new
what it is
Octave sells specialty insurance and insurance distribution services through 2 business lines.
how it gets paid
Last year Octave Specialty Grp made $143M in revenue. Specialty property and casualty programs was the main engine at $60M, or 42% of sales.
why it's growing
Revenue grew 55.8% last year to ~$143M. One noisy quarter printed about $103M (lumpy vs the full year — not four quarters at that run rate).
what just happened
Octave lost $5.11 a share while revenue reached $103M in the latest quarter.
At a glance
B balance sheet — gets the job done, barely
5/100 earnings predictability — expect surprises
0.1% return on capital — nothing to write home about
-$0.13 fy2024 eps est
n/m fy2024 rev est — $6M tick was bad feed vs ~$143M actuals
xvary composite: 44/100 — below average
What they do
Octave sells specialty insurance and insurance distribution services through 2 business lines.
You get 2 engines, not 1. Specialty property and casualty insurance means it writes niche policies, and insurance distribution means it sells and manages those policies for others. With 380 employees, one shop can control the policy, the placement, and the paperwork.
financials
micro-cap
insurance
distribution
specialty-risk
How they make money
$143M
annual revenue · their business grew +55.8% last year
Specialty property and casualty programs
$60M
Commercial liability risks
$40M
Personal liability risks
$20M
Insurance distribution services
$23M
The products that matter
places niche insurance business
Insurance Distribution
$96M disclosed revenue · +15%
This segment is shown here at $96M, and property & casualty premium production grew 15% to $303M last quarter. That's where the visible momentum sits.
$303M premium production
assumes and manages insurance risk
Underwriting Platforms
$47M disclosed revenue
This piece is listed at $47M. It matters because underwriting is where an insurance company proves discipline — or finds out it bought volume instead of value.
execution risk
new MGA and startup pipeline
De novo launches
2026 pipeline cited
Management pointed to 2026 cash flow expectations and a pipeline for new startups. With EPS still expected at -$0.13, you need those launches to add earnings, not just more entities.
story still forming
Key numbers
$143M
annual revenue
This is the size of the whole business. For a company worth about $230M, that is a small market price for a real insurance operation.
$103M
latest quarter
One quarter produced $103M in revenue. That is 72% of the full-year revenue figure, so the run rate is lumpy.
−$5.11
quarterly EPS
This is the bottom line in plain English: a quarterly loss of $5.11 per share — the tile now shows the minus sign the headline uses.
0.1%
return on capital
For every $100 the business puts to work, it earns about 10 cents. That is why the stock still looks cheap.
Financial health
-
balance sheet grade
B — adequate — nothing special
-
risk rank
4 — safer than 20% of stocks
-
price stability
20 / 100
B — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for OSG right now.
same standard. no invented return math.
source: institutional data · return history unavailable
What just happened
missed estimates
Octave lost $5.11 a share while revenue reached $103M in the latest quarter.
Quarter revenue about $103M with EPS −$5.11 — top line can look large in one quarter while the bottom line is still a wreck. Treat +186% vs. prior year as optional noise unless your source pins the prior comp.
+186%
rev. growth (vs. prior year · noisy)
the number that mattered
Revenue mattered most: $103M in one quarter is a huge chunk of the $143M annual total.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
OSG's problem is specific: it has already shown 56% revenue growth and $303M of premium production, but it still shows just 0.1% return on capital. If you own it, you are betting the economics arrive before the market loses patience.
Acquisition integration without better returns
The model depends on buying and combining smaller insurance operations. Revenue grew 56% last year, but return on capital is still 0.1%. If deals add size without earnings, you are just collecting subsidiaries.
0.1% return on capital is the warning sign
Underwriting discipline slips
Underwriting Platforms are listed at $47M. That's the part of the business where growth becomes bad growth if pricing or claims discipline is weak. Insurance businesses often look fine right until the losses arrive.
$47M segment disclosure tied to risk-taking
Institutional selling in a tiny float
Institutions own 81% of the stock and cut holdings by 9% last quarter. In a $230M company, that kind of selling pressure matters because the shareholder base is concentrated and the stock is small.
81% owned · 9% cut last quarter
Disclosure stays messy
This snapshot shows a $6M annual revenue line alongside $96M and $47M segment disclosures. If the story is hard to reconcile, investors usually assign less trust to the numbers and a lower valuation with it.
$6M versus $143M disclosed segment total
A company showing 56% revenue growth and $303M of premium production still produced just 0.1% return on capital and an expected -$0.13 EPS. If economics do not catch up, the roll-up story gets smaller fast.
source: institutional data · regulatory filings · risk analysis
Pay attention to
#
economics
Does return on capital move off 0.1%
This is the cleanest test of whether growth is becoming value creation. If that number stays pinned near zero, the story has not improved.
cal
next report
2026 cash flow commentary
Management flagged 2026 cash flow expectations on the Feb 24 call. You want specifics, not broad optimism.
#
growth quality
Premium production versus earnings
$303M of premium production sounds good. Watch whether future updates pair that with better profit metrics instead of just bigger volume.
!
subsidiary execution
Everspan leadership changes
Leadership turnover can be healthy or it can be a tell. In a small insurance platform, you do not ignore operating changes at key units.
Analyst rankings
earnings predictability
5 / 100
in human-speak, analysts do not see a stable earnings pattern here yet. Expect surprises.
balance sheet grade
B
That means the balance sheet is functional, not bulletproof. Fine if execution improves. A problem if it doesn't.
risk rank
4
Rank 4 means safer than 20% of stocks. That's another way of saying you are not hiding here when markets get messy.
source: institutional data
Institutional activity
institutional ownership data for OSG is being compiled.
source: institutional data
source: institutional data
Price targets
3-5 year target range
n/a
n/a
n/a
target midpoint · n/a from current
target data not available
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/mo
The deep dive
OSG
xvary deep dive
osg
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it